Pharmaceutical formulations of resveratrol and methods of use thereof
AssigneePharmascience Inc.
InventorsJohn M. Pezzuto, Richard C. Moon, Mei-Shiang Jang, Aomar Ouali, Shengzhao Lin, Karla Slowing Barillas
Life of this patent
Estimating the term…
Abstract
A method is provided for preventing or treating skin conditions, disorders or diseases, such as may be associated with or caused by inflammation, sun damage or natural aging. The method involves administration, preferably topical administration, of an active agent selected from the group consisting of resveratrol, pharmacologically acceptable salts, esters, amides, prodrugs and analogs thereof, and combinations of any of the foregoing. Pharmaceutical formulations for use in conjunction with the aforementioned method are provided as well.
Claims37
A method for treating an individual susceptible to or afflicted with a skin condition, disorder or disease selected from the groups consisting of psoriasis, contact dermatitis, atopic dermatitis, actinic keratosis, a keratinization disorder, an epidermolysis bullosa disease, exfoliative dermatitis, seborrheic dermatitis, erythema multiforme, erythema nodosum, discoid lupus erythematosus, and dermatomyositis, comprising administering to the susceptible or affected area of the individual's skin a therapeutically effective anti-inflammatory amount of a topical pharmaceutical formulation that comprises a topical carrier and an active agent selected from the group consisting of resveratrol, pharmacologically acceptable salts, esters, amides, prodrugs and analogs thereof, and combinations of any of the foregoing.
A method for preventing or treating an individual susceptible to or afflicted with a skin condition, disorder or disease selected from the group consisting of psoriasis, contact dermatitis, atopic dermatitis, actinic keratosis, a keratinization disorder, an epidermolysis bullosa disease, exfoliative dermatitis, seborrheic dermatitis, erythema multiforme, erythema nodosum, discoid lupus erythematosus, and dermatomyositis, comprising administering to a susceptible or affected individual a pharmaceutical formulation comprised of an isotropically clear dispersion containing a therapeutically effective anti-inflammatory amount of an active agent selected from the group consisting of resveratrol, pharmacologically acceptable salts, esters, amides, prodrugs and analogs thereof, and combinations of any of the foregoing.
Dependencies are inferred from the claim text.